Videos

Tailoring Treatments to Patients' Genetics, NPR's Morning Edition, September 11, 2008

Experimental Drug Leads to Life Changing News for Cancer Patients

Personalized Medicine – How the Human Genome Era Will Usher in a Healthcare Revolution

Frost & Sullivan on Personalized Medicine

Pharmacogenomics – the Future

Dr. Giselle Sholler – Dr. Sholler Discusses Her Relationship with the Ishan Gala Foundation and Her Passion for Finding a Cure for Neuroblastoma.

News

In the News

The explosion of knowledge in personalized medicine and pharmacogenomics presents both an opportunity for understanding cancer treatments and a challenge for organizing the information. This page is part of our continuing effort to organize information for your review.

Business Review West Michigan
Article: Grand Rapids Company Intervention Insights Centered on Personalized Medicine

Newsweek
Article: Curing Cancer – What treatable tumors teach us about improving the odds in the deadliest cases

Grand Rapids Business Journal
Article: Start-up uses VAI IP for molecular cancer solution

ASCO Post
Article: A Conversation with Paul A. Bunn, Jr. MD - Personalized Medicine and Lung Cancer Dr. Paul A. Bunn Jr. states: "The average oncologist ought to know that patients should undergo genetic testing before initial treatment. These physicians need to work with colleagues to get an adequate biopsy. If they don't know about these new options, they should call a colleague and/or attend a CME course. The days of giving treatment without understanding the genetics of the tumor are over. The good news is that these new treatments are oral therapies that have far fewer side effects."

The Baltimore Sun
Article: Hopkins receives $30 million gift

Hyundai Hope on Wheels
Dr. Giselle Sholler at the University of Vermont received a generous grant from Hyundai for her work with pediatric neuroblastoma. The Intervention Insights is the platform used in the study. Click here

Article:

Personalized Medicine Coalition
Article: The Case for Personalized Medicine Article

The Hastings Center - Bioethics Briefing Book for Journalists, Policymakers, and Campaigns
Chapter: Personalized Medicine and Genomics Chapter 29

The ROI for Targeted Therapies
Article: A Strategic Perspective Assessing the Barriers and Incentives for Adopting Personalized Medicine Article

NIH/National Institute of General Medical Sciences – Medicines by Design
This educational booklet about pharmacology explains how scientists unravel the many ways medicines work in the body and how this information guides the hunt for future drugs. Medicines By Design describes the science of pharmacology, discusses how drugs work in the body, and presents some of the latest research developments in the field.
Chapter: Medicine by Design Chapter

Personalized Medicine
Personalized medicine has the potential to transform healthcare through earlier diagnosis, more effective prevention, and improved treatment of disease.
Website: www.genome.gov/13514107

Pharmacogenomics: The Promise of Personalized Medicine
Pharmacogenetics and pharmacogenomics deal with the genetic basis underlying variable drug response in individuals.
Website: www.aapsj.org/view.asp?art=ps020104

Pharmacogenomics: When Drug Treatment Becomes Personalized Medicine
Website: www.mayoclinic.com/health/personalized-medicine/CA00078

Pharmacogenomics and the Brave New World of Personalized Medicine
Angelo De Palma, Ph.D. Pharmaceutical Manufacturing
Website: www.pharmamanufacturing.com/articles/2006/047.html

Personalized Medicine: Transforming Drug Discovery and Development
Ronenn Roubenoff, MD, MHS, FACP, FACR, Sr. Director, Molecular Medicine Millennium Pharmaceuticals, Cambridge, MA Adjunct Professor of Nutrition & Medicine, Tufts University, Boston, MA
Presentation: Transforming Drug Discovery and Development

The Power of Personalized Medicine: Changing Medicine and People's Lives
Geoffrey S. Ginsburg, M.D., Ph.D. Director, Center for Genomic Medicine Duke University
Presentation: The Power of Personalized Medicine